List of insiders holdings for AMICUS THERAPEUTICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Redmile Group LLC Green Jeremy 10% Owner | 2025-02-14 20:00:35 | 14,184,495 0 | 14,184,495 | Form 13G |
| 2 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 2025-08-14 16:25:50 | 7,412,830 0 | 7,412,830 | Form 13G |
| 3 | NEW ENTERPRISE ASSOCIATES 11 LP NEA PARTNERS 11 LP NEA 11 GP LLC BASKETT FOREST DRANT RYAN D KOLLURI KRISHNA KITTU SANDELL SCOTT D 10% Owner | 2012-03-09 15:55:05 | 4,584,311 0 | 4,584,311 | Form 4 |
| 4 | BARRIS PETER J 10% Owner | 2012-03-09 15:54:27 | 0 4,584,311 | 4,584,311 | Form 4 |
| 5 | KRAMLICH C RICHARD 10% Owner | 2012-03-09 15:53:36 | 0 4,584,311 | 4,584,311 | Form 4 |
| 6 | NEWHALL CHARLES W III 10% Owner | 2012-03-09 15:52:56 | 0 4,584,311 | 4,584,311 | Form 4 |
| 7 | PERRY MARK W 10% Owner | 2012-03-09 15:52:38 | 0 4,584,311 | 4,584,311 | Form 4 |
| 8 | CHL Medical Partners II Side Fund L.P. 10% Owner | 2007-06-07 13:58:16 | 2,108,555 1,975,456 | 4,084,011 | Form 4 |
| 9 | NEW ENTERPRISE ASSOCIATES 11 LP NEA PARTNERS 11 LP NEA 11 GP LLC BARRETT M JAMES BASKETT FOREST DRANT RYAN D KOLLURI KRISHNA KITTU LINEHAN CHARLES M SANDELL SCOTT D TRAINOR III EUGENE A 10% Owner | 2007-06-07 20:28:23 | 3,659,157 0 | 3,659,157 | Form 4 |
| 10 | Garden State Life Sciences Venture Fund L P 10% Owner | 2007-06-07 10:41:25 | 1,419,762 1,064,822 | 2,484,584 | Form 4 |
| 11 | PROSPECT VENTURE PARTNERS II LP PROSPECT ASSOCIATES II L P PROSPECT MANAGEMENT CO II LLC TANANBAUM JAMES B SCHNELL DAVID HIRSCH RUSSELL C 10% Owner | 2013-01-28 17:13:59 | 2,240,752 0 | 2,240,752 | Form 13G |
| 12 | QUAKER BIO VENTURES LP 10% Owner | 2012-02-14 14:33:03 | 1,429,762 0 | 1,429,762 | Form 13G |
| 13 | CHL Medical Partners II L.P. 10% Owner | 2010-02-05 14:33:55 | 1,365,941 0 | 1,365,941 | Form 13G |
| 14 | Crowley John F Executive Chairman | 2024-03-15 19:14:06 | 927,013 0 | 927,013 | Form 4/A |
| 15 | Canaan Equity Partners III LLC CANAAN EQUITY III LP CANAAN EQUITY III ENTREPRENEURS LLC BALEN JOHN V GREEN L STEPHEN DEEPAK KAMRA KOPCHINSKY GREGORY RUDNICK SETH RUSSO GUY M YOUNG ERIC A 10% Owner | 2010-02-10 16:10:48 | 552,191 0 | 552,191 | Form 13G |
| 16 | Do Hung Chief Science Officer | 2021-04-08 20:05:06 | 448,617 0 | 448,617 | Form 4 |
| 17 | Quimi Daphne Chief Financial Officer | 2023-01-19 18:16:09 | 398,532 0 | 398,532 | Form 4 |
| 18 | Barth Jay Chief Medical Officer | 2020-10-02 16:34:33 | 177,870 20 | 177,890 | Form 4 |
| 19 | Dilone Enrique SVP, Technical Operations | 2015-06-23 20:09:25 | 158,598 0 | 158,598 | Form 4 |
| 20 | LOVE TED W Director | 2020-06-08 16:57:03 | 149,574 0 | 149,574 | Form 4 |
| 21 | Baird William D III Chief Financial Officer | 2018-10-17 18:28:05 | 141,622 0 | 141,622 | Form 4 |
| 22 | Weinhoff Gregory M Director | 2008-08-18 16:05:37 | 0 129,943 | 129,943 | Form 4 |
| 23 | Ludwig Karin Senior VP, Clinical Research | 2007-05-30 19:56:54 | 106,667 0 | 106,667 | Form 3 |
| 24 | Patterson Matthew R Acting CEO & President | 2011-04-19 15:53:18 | 106,547 0 | 106,547 | Form 4 |
| 25 | Lockhart David J Chief Scientific Officer | 2013-06-20 16:10:15 | 100,000 0 | 100,000 | Form 4 |
| 26 | Gershkowitz Jayne SVP, Chief Patient Advocate | 2015-07-01 17:27:09 | 99,396 0 | 99,396 | Form 4 |
| 27 | Andrews Kurt J. SVP, Human Resources | 2018-07-05 16:25:39 | 90,469 0 | 90,469 | Form 4 |
| 28 | Boudes Pol F Chief Medical Officer | 2012-06-06 16:44:04 | 80,000 0 | 80,000 | Form 4 |
| 29 | Baldry Mark VP Global Marketing | 2015-06-04 18:56:39 | 75,000 0 | 75,000 | Form 4 |
| 30 | Valenzano Ken SVP, Pharmacology & Biology | 2015-07-15 17:05:48 | 71,687 0 | 71,687 | Form 4 |
| 31 | ESSNER ROBERT Director | 2021-06-14 19:14:06 | 67,226 0 | 67,226 | Form 4 |
| 32 | Peist Kenneth VP, Legal & IP | 2016-01-06 16:18:25 | 63,874 0 | 63,874 | Form 4 |
| 33 | Simon Mark Sr. VP, Business Development | 2007-05-30 19:52:19 | 63,334 0 | 63,334 | Form 3 |
| 34 | Bloch Stephen M Director | 2009-02-12 13:31:12 | 0 61,700 | 61,700 | Form 4 |
| 35 | David Allsop SVP International | 2015-04-28 17:01:43 | 50,000 0 | 50,000 | Form 4 |
| 36 | Kirk John VP, Regulatory Affairs | 2015-06-03 19:18:58 | 45,000 0 | 45,000 | Form 4 |
| 37 | Schaeffer Orlov S Nicole SVP, HR & Leadership Devt | 2012-02-17 14:38:28 | 45,000 0 | 45,000 | Form 4 |
| 38 | Branch Douglas A VP, General Counsel & Sec. | 2007-05-30 19:47:28 | 40,002 0 | 40,002 | Form 3 |
| 39 | Winterbottom Joan SVP, Human Resources | 2013-06-20 16:11:11 | 40,000 0 | 40,000 | Form 4 |
| 40 | Macaluso Peter M VP & Corporate Counsel | 2013-06-20 16:12:21 | 35,000 0 | 35,000 | Form 4 |
| 41 | Winkler Robert E VP, Clin Research & Operations | 2012-06-06 16:48:12 | 35,000 0 | 35,000 | Form 4 |
| 42 | Palling David Sr VP, Technical Operations | 2009-06-30 12:53:51 | 34,040 0 | 34,040 | Form 4 |
| 43 | Dentzer James E Chief Financial Officer | 2009-10-01 13:49:13 | 32,075 0 | 32,075 | Form 4 |
| 44 | Licholai Gregory P VP, Medical Affairs | 2009-02-05 12:02:54 | 27,000 0 | 27,000 | Form 4 |
| 45 | BARER SOL J Director | 2016-06-13 14:37:44 | 20,000 0 | 20,000 | Form 4 |
| 46 | Shenker Andrew VP, Clinical Research | 2009-02-05 12:16:10 | 18,000 0 | 18,000 | Form 4 |
| 47 | HAYDEN DONALD J JR Director | 2018-06-11 16:44:59 | 17,807 0 | 17,807 | Form 4 |
| 48 | Topper James N Director | 2014-06-16 12:50:45 | 15,000 0 | 15,000 | Form 4 |
| 49 | John McAdam M VP, Finance & Accounting | 2010-06-17 11:48:35 | 15,000 0 | 15,000 | Form 4 |
| 50 | BARRETT M JAMES Director 10% Owner | 2014-06-16 11:35:16 | 15,000 0 | 15,000 | Form 4 |
| 51 | Doshi Dipal SVP Strategy & Bus Dev | 2015-07-09 18:26:35 | 14,206 0 | 14,206 | Form 4 |
| 52 | NEFF P SHERRILL Director | 2010-06-17 09:52:54 | 10,000 0 | 10,000 | Form 4 |
| 53 | BARKAS ALEXANDER E Director | 2011-06-14 14:42:26 | 10,000 0 | 10,000 | Form 4 |
| 54 | Gilmore Geoffrey SVP & General Counsel | 2012-03-13 13:28:06 | 10,000 0 | 10,000 | Form 4 |
| 55 | SBLENDORIO GLENN Director | 2026-04-27 16:42:13 | 0 0 | 0 | Form 4 |
| 56 | WHITMAN BURKE W Director | 2026-04-27 16:42:31 | 0 0 | 0 | Form 4 |
| 57 | MCGLYNN MARGARET G Director | 2026-04-27 16:42:58 | 0 0 | 0 | Form 4 |
| 58 | WHEELER CRAIG A Director | 2026-04-27 16:43:16 | 0 0 | 0 | Form 4 |
| 59 | ROBERTS EIRY Director | 2026-04-27 16:41:52 | 0 0 | 0 | Form 4 |
| 60 | Bleil Lynn Dorsey Director | 2026-04-27 16:41:34 | 0 0 | 0 | Form 4 |
| 61 | Kelly Michael Aaron Director | 2026-04-27 16:41:19 | 0 0 | 0 | Form 4 |
| 62 | RAAB MICHAEL Director | 2026-04-27 16:40:32 | 0 0 | 0 | Form 4 |
| 63 | Prout Samantha Chief Accounting Officer | 2026-04-27 16:39:41 | 0 0 | 0 | Form 4 |
| 64 | Castelli Jeff Chief Development Officer | 2026-04-27 16:39:13 | 0 0 | 0 | Form 4 |
| 65 | Clark David Michael Chief People Officer | 2026-04-27 16:38:50 | 0 0 | 0 | Form 4 |
| 66 | Rosenberg Ellen Chief Legal Officer | 2026-04-27 16:38:32 | 0 0 | 0 | Form 4 |
| 67 | Harford Simon N.R. Chief Financial Officer | 2026-04-27 16:37:52 | 0 0 | 0 | Form 4 |
| 68 | Campbell Bradley L President and CEO | 2026-04-27 16:37:24 | 0 0 | 0 | Form 4 |
| 69 | Yu Julie VP Clinical Ops & Data Mgmt | 2015-06-16 20:14:59 | 0 0 | 0 | Form 4 |
| 70 | GLAXOSMITHKLINE PLC Former 10% Owner (1) | 2014-10-28 14:35:36 | 0 0 | 0 | Form 4 |
| 71 | FHM IV LP Frazier Healthcare V LP FHM V LP FHM V LLC FRAZIER HEALTHCARE IV LP FRAZIER AFFILIATES IV LP 10% Owner | 2016-03-08 14:35:34 | 0 0 | 0 | Form 13G |
| 72 | Mount Sinai School of Medicine of New York University 10% Owner | 2007-06-07 15:44:37 | 0 0 | 0 | Form 4 |